Clinical Trial Update: Topical Gentamicin Nonsense Suppression Therapy of EB [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial investigating topical gentamicin as a nonsense suppression therapy for Epidermolysis Bullosa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa

Drugs mentioned

• Gentamicin (topical) (gentamicin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Epidermolysis Bullosa | Phase 1, Phase 2 | Status: COMPLETED